Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi survey.
- DOI
- 10.1007/s00432-026-06583-w
- Published
- 2026 Sep 2
- Container
- Journal of cancer research and clinical oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00432-026-06583-w,
title = {Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi survey.},
author = {Biedenweg B and Ruppert T and Kohlmann T and Danner M and Mehnert-Theuerkauf A and Lüftner D and Filippig U and Ziemann J and Osowski U and Kaskel P},
year = {2026},
journal = {Journal of cancer research and clinical oncology},
doi = {10.1007/s00432-026-06583-w},
url = {https://doi.org/10.1007/s00432-026-06583-w}
}RIS
TY - JOUR TI - Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi survey. AU - Biedenweg B AU - Ruppert T AU - Kohlmann T AU - Danner M AU - Mehnert-Theuerkauf A AU - Lüftner D AU - Filippig U AU - Ziemann J AU - Osowski U AU - Kaskel P PY - 2026 JO - Journal of cancer research and clinical oncology DO - 10.1007/s00432-026-06583-w UR - https://doi.org/10.1007/s00432-026-06583-w ER -
APA
B, B., T, R., T, K., M, D., A, M., D, L., U, F., J, Z., U, O., & P, K. (2026). Time to subsequent therapy (TTST) as an endpoint in clinical studies: development of standardized documentation of subsequent therapy through systematic literature review, expert interviews, and Delphi survey.. Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-026-06583-w
Source records
- pubmed · retrieved 2026-09-26T01:40:22.424Z